"GABA Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA).
| Descriptor ID |
D018755
|
| MeSH Number(s) |
D27.505.519.625.240.200 D27.505.696.577.240.200
|
| Concept/Terms |
GABA Agonists- GABA Agonists
- Agonists, GABA
- gamma-Aminobutyric Acid Agonists
- Acid Agonists, gamma-Aminobutyric
- Agonists, gamma-Aminobutyric Acid
- gamma Aminobutyric Acid Agonists
- GABA Receptor Agonists
- Agonists, GABA Receptor
- Receptor Agonists, GABA
- gamma-Aminobutyric Acid Agonist
- Acid Agonist, gamma-Aminobutyric
- Agonist, gamma-Aminobutyric Acid
- gamma Aminobutyric Acid Agonist
- GABA Agonist
- Agonist, GABA
- GABA Receptor Agonist
- Agonist, GABA Receptor
- Receptor Agonist, GABA
|
Below are MeSH descriptors whose meaning is more general than "GABA Agonists".
Below are MeSH descriptors whose meaning is more specific than "GABA Agonists".
This graph shows the total number of publications written about "GABA Agonists" by people in this website by year, and whether "GABA Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "GABA Agonists" by people in Profiles.
-
Brohan J, Goudra BG. The Role of GABA Receptor Agonists in Anesthesia and Sedation. CNS Drugs. 2017 Oct; 31(10):845-856.
-
Reddy K, Reife R, Cole AJ. SGE-102: a novel therapy for refractory status epilepticus. Epilepsia. 2013 Sep; 54 Suppl 6:81-3.
-
Burton NC, Schneider JS, Syversen T, Guilarte TR. Effects of chronic manganese exposure on glutamatergic and GABAergic neurotransmitter markers in the nonhuman primate brain. Toxicol Sci. 2009 Sep; 111(1):131-9.
-
Whyte J, Myers R. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. Am J Phys Med Rehabil. 2009 May; 88(5):410-8.
-
Greenberg SM, Rosand J, Schneider AT, Creed Pettigrew L, Gandy SE, Rovner B, Fitzsimmons BF, Smith EE, Edip Gurol M, Schwab K, Laurin J, Garceau D. A phase 2 study of tramiprosate for cerebral amyloid angiopathy. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4):269-74.
-
Hirata H, Okamoto K, Tashiro A, Bereiter DA. A novel class of neurons at the trigeminal subnucleus interpolaris/caudalis transition region monitors ocular surface fluid status and modulates tear production. J Neurosci. 2004 Apr 28; 24(17):4224-32.
-
Hirata H, Okamoto K, Bereiter DA. GABA(A) receptor activation modulates corneal unit activity in rostral and caudal portions of trigeminal subnucleus caudalis. J Neurophysiol. 2003 Nov; 90(5):2837-49.